Global Pharmaceuticals, Biotechnology & Life Sciences
Products
Full Paper
Price: £195.00
Description: The report includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
Published Date: 17/01/2012
Category: Therapies & Markets
Research Report Decription
Global Pharmaceuticals, Biotechnology & Life Sciences industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global pharmaceuticals, biotechnology & life sciences market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
- Save time carrying out entry-level research by identifying the size,
growth, major segments, and leading players in the pharmaceuticals,
biotechnology & life sciences market in the global
- Use the Five
Forces analysis to determine the competitive intensity and therefore
attractiveness of the globalpharmaceuticals, biotechnology & life
sciences market
- Leading company profiles reveal details of key
pharmaceuticals, biotechnology & life sciences market players’
global operations and financial performance
- Add weight to presentations
and pitches by understanding the future growth prospects of the Global
pharmaceuticals, biotechnology & life sciences market with five year
forecasts
- Identify the most important regions for pharmaceuticals,
biotechnology & life sciences, with the global market segmented by
geography for 2010
Key Questions Answered:
- What was the size of the Global pharmaceuticals, biotechnology & life sciences market by value in 2010?
- What will be the size of the Global pharmaceuticals, biotechnology & life sciences market in 2015?
- What factors are affecting the strength of competition in the Global pharmaceuticals, biotechnology & life sciences market?
- How has the market performed over the last five years?
- Who are the top competitiors in the global's pharmaceuticals, biotechnology & life sciences market?
Companies Mentioned:
Novartis AG, Pfizer, Roche Holdings, Sanofi-Aventis SA
Paper Highlights:
- The global pharmaceuticals, biotechnology, and life sciences industry group is composed of the pharmaceuticals market, the biotechnology market, and the life sciences tools and services market.
- The global pharmaceuticals, biotechnology, and life sciences industry group generated total revenues of $1,001 billion in 2010, representing a compound annual growth rate (CAGR) of 6.8% for the period spanning 2005-2010.
- Pharmaceuticals proved the most lucrative for the global pharmaceuticals, biotechnology, and life sciences industry group in 2010, generating total revenues of $733.1 billion, equivalent to 73.2% of the industry group's overall value.
- The performance of the industry group is forecast to accelerate, with an anticipated CAGR of 7% for the five-year period 2010-2015, which is expected to drive the market to a value of $1,405 billion by the end of 2015.